We are hosting some guest blog posts from commissioners. Thanks to Paul Jenkins for the first entry!

Paul Jenkins of Rethink Mental Illness
In November last year, Rethink Mental Illness marked the 100th anniversary of the coining of the term by setting up an independent Commission on Schizophrenia, under the chairmanship of Professor Sir Robin Murray. The Commission is aiming to take stock of what we know about schizophrenia, the experiences of those individuals and families affected by it and make practical recommendations which could make a difference to peoples’ lives.
Last month we held the first of 4 public evidence-giving days at the Imperial War Museum which, appropriately enough, is the former site of the Royal Bethlehem Hospital.
The day involved two sessions of evidence. We started with evidence from service users and carers about their first-hand experience of living with schizophrenia. Some stories highlighted the possibility of recovery and provided some clear insights into what interventions made a difference.
The right medication had helped one individual, a personal budget and the scope to employ a personal assistant had been crucial in another case. In all cases some meaningful message of hope and the willingness of professionals to take the experiences and beliefs of services users and carers seriously were central.
Genuine hope must not be allowed, especially when resources are tight, to degenerate into trite policy prescriptions which ignore the complexity of what people experience with schizophrenia.
Such messages of hope are important and through the Commission we are keen to counter the implication of schizophrenia as an inevitable “life sentence” for those affected. However our witnesses were at pains to remind us that, with schizophrenia, recovery could be a long journey with setbacks as well as steps forward.

Imperial War Museum
One witness in particular reminded us how bad things could be and graphically captured the sense of bereavement resulting from her brother’s illness. Genuine hope must not be allowed, especially when resources are tight, to degenerate into trite policy prescriptions which ignore the complexity of what people experience with schizophrenia.
The discussion also reminded us of the forgotten groups living with schizophrenia. This entails both individuals with relatively stable symptoms but who live lonely neglected lives on the margins of society and those who have fallen altogether out of the care system and get caught up in homelessness or the criminal justice system.
In the afternoon the focus shifted to causes and concepts with presentations from many leading researchers such Mike Owen, Richard Bentall, Craig Morgan, Jim van Os and Diana Rose.
The name and the concept remain difficult. Both genetics and psychology increasingly suggest a phenomenon with fuzzy edges…
This has not always been easy territory. The question of what schizophrenia is or isn’t and what causes it or doesn’t have been the source of fierce controversy and the Schizophrenia Wars fought in the past have caused much bitterness and have perhaps distracted attention at times from building a coherent case for better outcomes.
It was encouraging therefore to see more consensus than dissonance amongst what was presented. This wasn’t the emergence of a “unifying theory of schizophrenia” but rather a clear sense that both biological and psychological schools of thought better recognise the contribution which each other’s work might bring to better understanding the symptoms which people experience, and the identification of effective interventions. The debate was usefully framed not as genes versus environment, but rather genes multiplied by environment.
The name and the concept remain difficult. Both genetics and psychology increasingly suggest a phenomenon with fuzzy edges and significant overlap both with other mental disorders but also with experiences in the wider population which are not classified as mental illness.
They also point to the need to respond to each person’s schizophrenia in a different way taking account of individual histories and presenting symptoms and not prescribing a one size fits all treatment – here’s your diagnosis – here’s your pill. Such a more personalised approach might improve outcomes.
Schizophrenia affects half a million people in this country and their families – and a hundred years after the term was coined it remains poorly understood
The event was attending by over 150 people during the course of the day, most of them with direct or family experience of schizophrenia and they too were able to add their voice. We will be holding 3 similar events over the next 4 months one in Manchester and two more in London. Details of how to attend are able on the Commission’s website. We are also carrying out what we hope will be the largest survey conducted in this country of people affected by schizophrenia. 1000 people have already responded and the survey can again be accessed through the Commission’s website.
So, what are we trying to achieve? Schizophrenia affects half a million people in this country and their families – and a hundred years after the term was coined it remains poorly understood. It can be a devastating experience but hope is possible and outcomes could be improved if individuals and families get the right support at the right time.
Above all we need to lift the shroud of secrecy from this forgotten illness. So despite some of the controversies which surround it, it’s good to talk about schizophrenia.